InvestorsHub Logo
Followers 24
Posts 1480
Boards Moderated 0
Alias Born 10/05/2015

Re: Crazy Money post# 35170

Wednesday, 11/11/2015 11:15:42 AM

Wednesday, November 11, 2015 11:15:42 AM

Post# of 460336


Off to the gym which usually means the PPS rises

Just read this post on Seeking Alpha..........


Obviously there is a decent chance that this drug, Anavex 2-73, will prove out.

(Decent Chance) X (One of the largest markets in the pharma space) X (not an expensive therapy, just a pill) =

Gauruntee that Jim Cramer, his henchman Adam Feuerstein, and the likes of Martin Shkreli, will hammer the stock, regardless of the true value. Note that Martin Shkreli used to work for Cramer's former hedge fund.

My speculation above is not arbitrary. Adam Feuerstein has a BA in Political Science, and had no biotech background whatsoever when Jim Cramer hired him to work for him as a Biotech Reporter. Jim Cramer soon started qualifying everything that Feuerstein said as having come from a "Biotech Expert". Feuerstein's primary council is in fact a Doctor... but a Doctor that likely leans toward big pharma, given his direct ties. While statements from that Doctor would be considered potentially biased, coming from Feuerstein, the connection to Big Pharma dissappears, but is really only 1 layer deep, while Feuerstein can hide behind the first ammendment.

Feuerstein has made statements in the past that clearly communicate his working philosophy that the large Pharma's essentially have the rights to anything developed by small biotechs, with a small premium. So retail carries these high risk small cap biotechs until the egg does appear golden, then Feurstein, Cramer, and other known crooks like Cramer, hammer the companies down to a price more to the liking of large intitutional investors and or prespective purchasers in the Big Pharma realm. It's a two-fer. Coordinated trashing of promising biotechs means money on the way down, and money later on, after their associates hedge fund(s)' large pharma holdings reep the benefits that retail thought they had paid for.

I predict that this issue, with a clear history of gross abuse and gross negligence of inaction by the SEC will become another key topic in the continued presidential debates in the near future.

Perhaps your 15 minutes of fame is yet to come Mr. Fonteneau.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News